Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only,

A Class II recall has been issued for Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles (NDC 16729-458-15), manufactured for Accord Healthcare, Inc. by Intas Pharmaceuticals Limited. The recall was initiated due to the product being subpotent, according to the recall notice.

Most relevant for: Patients taking levothyroxine sodium 300 mcg tablets from this specific manufacturer who may not be receiving adequate thyroid hormone replacement due to subpotent medication.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.